Figure 1 | Scientific Reports

Figure 1

From: Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Figure 1

Measurement of clinical laboratory parameters. (A) Clinical details of healthy control subjects and low and moderately high parasitemic vivax malaria and dengue fever patients. HC (n = 40), LPVM (n = 23), MPVM (n = 40) and DF (n = 7). (B) Clinical laboratory parameters in a longitudinal cohort of vivax malaria patients. HC (n = 15) and a longitudinal cohort (FEB, DEF and CON stages) of vivax malaria patients (n = 15). **Indicates p < 0.001, *indicates 0.001 < p < 0.05 and NS indicates p > 0.05 based on a Mann-Whitney test. Complete lists of demographic and clinical details are provided under supplementary information (Tables S1 and S2).

Back to article page